PTGS2 and malignant colon neoplasm: Other studies have shown that treatment of COX-2-over-expressing HT29 human colon cancer cells with 30–120 μM fisetin causes the induction of apoptosis and down-regulation of COX-2 expression without affecting COX-1, and suppresses the secretion of prostaglandin E2 [34].